DE3579051D1 - Lipophile muramylpeptid-derivate mit einer makrophagen aktivierenden wirkung, die sie enthaltenden zusammensetzungen und verfahren zu ihrer herstellung. - Google Patents

Lipophile muramylpeptid-derivate mit einer makrophagen aktivierenden wirkung, die sie enthaltenden zusammensetzungen und verfahren zu ihrer herstellung.

Info

Publication number
DE3579051D1
DE3579051D1 DE8585400921T DE3579051T DE3579051D1 DE 3579051 D1 DE3579051 D1 DE 3579051D1 DE 8585400921 T DE8585400921 T DE 8585400921T DE 3579051 T DE3579051 T DE 3579051T DE 3579051 D1 DE3579051 D1 DE 3579051D1
Authority
DE
Germany
Prior art keywords
group
groups
lipophile
carbon atoms
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585400921T
Other languages
English (en)
Inventor
Nigel Phillips
Francoise Audibert
Jean-Marie Bernard
Louis Chedid
Pierre Lefrancier
Michel Level
Monique Parant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Application granted granted Critical
Publication of DE3579051D1 publication Critical patent/DE3579051D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DE8585400921T 1984-05-11 1985-05-10 Lipophile muramylpeptid-derivate mit einer makrophagen aktivierenden wirkung, die sie enthaltenden zusammensetzungen und verfahren zu ihrer herstellung. Expired - Fee Related DE3579051D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8407340A FR2564096B1 (fr) 1984-05-11 1984-05-11 Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir

Publications (1)

Publication Number Publication Date
DE3579051D1 true DE3579051D1 (de) 1990-09-13

Family

ID=9303899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585400921T Expired - Fee Related DE3579051D1 (de) 1984-05-11 1985-05-10 Lipophile muramylpeptid-derivate mit einer makrophagen aktivierenden wirkung, die sie enthaltenden zusammensetzungen und verfahren zu ihrer herstellung.

Country Status (8)

Country Link
US (2) US4939122A (de)
EP (1) EP0165123B1 (de)
JP (1) JPH0670080B2 (de)
AT (1) ATE55394T1 (de)
CA (1) CA1259750A (de)
DE (1) DE3579051D1 (de)
DK (1) DK164918C (de)
FR (1) FR2564096B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT85537B (pt) * 1986-08-18 1990-06-29 Univ Texas Processo para a preparacao de um sistema de administracao farmaceutica contendo peptidos apresentando quimiotaxia
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
JPH0832638B2 (ja) * 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
FR2664813B1 (fr) * 1990-07-18 1995-01-13 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
FR2692149B1 (fr) * 1992-06-12 1995-06-09 Vacsyn France Sa Composition adjuvante de l'immunite humorale et a mediation cellulaire n'induisant pas de reponse vis-a-vis de determinants auto-antigeniques.
US5462735A (en) * 1993-06-10 1995-10-31 The United States Of America As Represented By The Secretary Of Agriculture Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide
WO1997043308A1 (en) * 1996-05-10 1997-11-20 Endorex Corporation Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines
EP1909758A1 (de) * 2005-08-02 2008-04-16 I.D.M. Immuno-Designed Molecules Verfahren zur herstelung von liposomalen formulierungen
US20160280631A1 (en) * 2015-03-25 2016-09-29 Biosynthetic Technologies, Llc. Ester compounds including triesters having terminal vicinal acyl groups

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2343035C2 (de) * 1973-08-25 1982-04-01 Hoechst Ag, 6000 Frankfurt Pyroglutamyl-histidyl-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4310514A (en) * 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
US4315913A (en) * 1980-06-09 1982-02-16 Merck & Co. Inc. Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
GR78246B (de) * 1981-01-23 1984-09-26 Ciba Geigy Ag
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
ZA846192B (en) * 1984-08-09 1986-03-26 Merck Patent Gmbh Immunotherapeutic polypeptide agents
JPS6157597A (ja) * 1984-08-29 1986-03-24 Toshiyuki Hamaoka ムラミルペプチド活性エステル誘導体

Also Published As

Publication number Publication date
EP0165123B1 (de) 1990-08-08
DK209985A (da) 1985-11-12
US4939122A (en) 1990-07-03
JPH0670080B2 (ja) 1994-09-07
EP0165123A3 (en) 1986-03-05
JPS60252497A (ja) 1985-12-13
DK209985D0 (da) 1985-05-10
FR2564096A1 (fr) 1985-11-15
USRE35706E (en) 1997-12-30
EP0165123A2 (de) 1985-12-18
FR2564096B1 (fr) 1988-02-19
CA1259750A (fr) 1989-09-19
ATE55394T1 (de) 1990-08-15
DK164918C (da) 1993-01-25
DK164918B (da) 1992-09-07

Similar Documents

Publication Publication Date Title
DE3579051D1 (de) Lipophile muramylpeptid-derivate mit einer makrophagen aktivierenden wirkung, die sie enthaltenden zusammensetzungen und verfahren zu ihrer herstellung.
MY114672A (en) New erythromycin derivatives,processes for preparing them,the products thus prepared,pharmaceutical compositions containing them,and their use as medicaments
MX9803761A (es) Nuevos agentes de transfeccion y sus aplicaciones farmaceuticas.
EP0235725A3 (en) Heterocyclic compounds
ATE153708T1 (de) Kompositelektrode für elektrochemische verfahren und verfahren zu deren herstellung durch verbrennungssynthese ohne düse
DE3880922D1 (de) Faktor viii-analog, verfahren zu dessen herstellung und dieses enthaltende zusammensetzung.
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
NZ290757A (en) Delivery of nucleic acid into a cell
ATE124388T1 (de) Kosmetische zusammensetzungen.
ES482112A1 (es) Procedimiento de preparacion de nuevos derivados de 3,20- dioxo-4,9-dieno-21-hidroxilo-esteroides.
FR2572399B1 (fr) Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
ATE159948T1 (de) Spicamycinderivate und deren verwendung
DE69814991D1 (de) Copolymere aus alpha-olefin und cycloolefin und verfahren zu ihrer herstellung
KR940021058A (ko) 신규한 에스큘레틴 유도체 및 약학 조성물
IL91913A0 (en) Fluorosubstituted benzene derivatives,processes for the preparation thereof and diagnostic compositions containing the same
DE68915191D1 (de) Verwendung von Polyacrylat-Polymeren als Stabilisiermittel für Suspensionen, aus einer wasserunlösbaren Phase in einer wässerigen Phase erhaltene Suspensionen und deren Herstellung.
ATE40352T1 (de) Neue carbacyclinamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
PH24709A (en) Allylmercaptoacetylsydnonimines and pharmaceutical compositions thereof
KR960004348A (ko) 폴리알킬피페리딘 화합물
ATE231136T1 (de) Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften, verfahren zu deren herstellung und pharmazeutischen zusammenstellungen, die sie enthalten
FR2632521B1 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions pharmaceutiques qui les contiennent
HUT55349A (en) Process for producing benzanilide derivatives and pharmaceutical compositions comprising same
JPS5795950A (en) Novel hexapeptide, manufacture, use as drug and composition
ES454283A1 (es) Procedimiento para la produccion de un peptido.
KR870002100A (ko) 설포닐이소(티오)우레아 유도체의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee